Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C063002 |
2,3-dimethoxy-1,4-naphthoquinone |
2,3-dimethoxy-1,4-naphthoquinone results in increased expression of TPX2 mRNA | increases expression | 19031421
|
D016604 |
Aflatoxin B1 |
Aflatoxin B1 affects the expression of TPX2 protein | affects expression | 20106945
|
C015001 |
arsenite |
arsenite results in decreased expression of TPX2 mRNA | decreases expression | 18929588
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of TPX2 mRNA | decreases expression | 19150397 20382639
|
C053541 |
bicalutamide |
bicalutamide results in decreased expression of TPX2 mRNA | decreases expression | 15638997
|
C006780 |
bisphenol A |
bisphenol A results in decreased expression of TPX2 mRNA | decreases expression | 17706920
|
C006780 |
bisphenol A |
LHB protein affects the reaction [bisphenol A results in decreased expression of TPX2 mRNA] | affects reaction|decreases expression | 17706920
|
D002104 |
Cadmium |
Cadmium results in increased expression of TPX2 mRNA | increases expression | 19031421
|
D002251 |
Carbon Tetrachloride |
Carbon Tetrachloride affects the expression of TPX2 mRNA | affects expression | 17484886
|
D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of TPX2 mRNA | decreases expression | 20106945
|
D004041 |
Dietary Fats |
Dietary Fats results in decreased expression of TPX2 mRNA | decreases expression | 18042831
|
C051890 |
irinotecan |
irinotecan metabolite results in decreased expression of TPX2 mRNA | decreases expression | 15956246
|
C051890 |
irinotecan |
irinotecan results in decreased expression of TPX2 mRNA | decreases expression | 15956246
|
D008748 |
Methylcholanthrene |
Methylcholanthrene results in increased expression of TPX2 mRNA | increases expression | 20713471
|
D015741 |
Metribolone |
Metribolone results in increased expression of TPX2 mRNA | increases expression | 17010196
|
C080955 |
N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide |
N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide results in decreased expression of TPX2 mRNA | decreases expression | 11494140
|
D009532 |
Nickel |
Nickel results in increased expression of TPX2 mRNA | increases expression | 19031421
|
C041786 |
palm oil |
palm oil results in decreased expression of TPX2 mRNA | decreases expression | 18042831
|
C487081 |
PXD101 |
PXD101 results in decreased expression of TPX2 mRNA | decreases expression | 19606018
|
C017947 |
sodium arsenite |
sodium arsenite results in decreased expression of TPX2 mRNA | decreases expression | 17998272
|
D013750 |
Tetrachloroethylene |
Tetrachloroethylene results in increased expression of TPX2 mRNA | increases expression | 19031421
|
D013755 |
Tetradecanoylphorbol Acetate |
Tetradecanoylphorbol Acetate results in increased expression of TPX2 mRNA | increases expression | 19031421
|
C496197 |
trans-10,cis-12-conjugated linoleic acid |
trans-10,cis-12-conjugated linoleic acid results in decreased expression of TPX2 mRNA | decreases expression | 17951470
|
D014212 |
Tretinoin |
Tretinoin results in decreased expression of TPX2 mRNA | decreases expression | 16249480
|
C012589 |
trichostatin A |
trichostatin A results in decreased expression of TPX2 mRNA | decreases expression | 19606018
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D055371 |
Acute Lung Injury |
|
Nickel |
4.44 | 16166738 |
MESH:D000236 |
Adenoma |
|
Methylcholanthrene |
3.41 | 6695378 10545420 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
4.55 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
4.75 | 17306315 16712894 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
3.49 | 15955085 |
MESH:D001161 |
Arteriosclerosis |
|
Dietary Fats |
3.74 | 15238619 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
2.98 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
2.23 | 16292516 |
MESH:D001249 |
Asthma |
|
Tretinoin |
2.30 | 16456186 |
MESH:D050197 |
Atherosclerosis |
|
Cadmium |
6.81 | 15687053 |
MESH:D050197 |
Atherosclerosis |
|
Methylcholanthrene |
6.81 | 11922910 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
4.25 | 16935849 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
3.47 | 16206674 16197459 |
MESH:D001862 |
Bone Resorption |
|
bisphenol A |
3.72 | 11985600 |
MESH:D001943 |
Breast Neoplasms |
|
bisphenol A |
2.91 | 17123778 |
MESH:D001943 |
Breast Neoplasms |
|
Dietary Fats |
2.91 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Methylcholanthrene |
2.91 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Nickel |
2.91 | 15986119 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachloroethylene |
2.91 | 15986119 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
2.91 | 16873071 16443354 16166294 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
4.44 | 16813970 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Carbon Tetrachloride |
3.63 | 16050911 15673190 16192424 15721981 3786805 16097048 10355542 18705752 16011737 16124888 16227642 15700767 |
MESH:D002277 |
Carcinoma |
|
Methylcholanthrene |
3.85 | 10545420 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
5.01 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Aflatoxin B1 |
6.39 | 12619106 12907637 21507988 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Carbon Tetrachloride |
6.39 | 18788625 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
6.39 | 16507464 17306315 15276417 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
6.39 | 1917145 |
MESH:D002278 |
Carcinoma in Situ |
|
bisphenol A |
4.84 | 17123778 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
7.37 | 18572023 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tetradecanoylphorbol Acetate |
7.37 | 18922899 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
7.37 | 16051514 16096774 |
MESH:D002386 |
Cataract |
|
Tretinoin |
3.01 | 17460283 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
20.01 | 20889678 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cadmium |
20.01 | 17332340 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
20.01 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Methylcholanthrene |
20.01 | 16192471 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
20.01 | 20056578 19524636 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
4.44 | 16129372 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
2.80 | 19486331 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
5.01 | 16461808 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
2.61 | 9407595 |
MESH:D003092 |
Colitis |
|
Tretinoin |
3.55 | 17035595 |
MESH:D003110 |
Colonic Neoplasms |
|
arsenite |
4.00 | 15037631 |
MESH:D003110 |
Colonic Neoplasms |
|
irinotecan |
4.00 | 17287894 17725105 |
MESH:D015179 |
Colorectal Neoplasms |
|
irinotecan |
2.36 | 16391804 18259882 18509181 16303861 15273666 17159606 17454858 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
1.81 | 17551590 8800419 14991402 9211117 10589399 9224671 9664655 16925845 9125849 9142499 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
Nickel |
3.80 | 19470301 17100760 17244072 |
MESH:D003877 |
Dermatitis, Contact |
|
Nickel |
4.49 | 2952479 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Carbon Tetrachloride |
2.00 | 17522070 6623471 7179309 7440962 16177239 15998439 15968718 3732212 15027814 7120509 10092053 19336974 19085960 11566570 6884620 16227642 4309450 3786805 10915739 21278145 9327722 2869522 |
MESH:D050171 |
Dyslipidemias |
|
Dietary Fats |
3.34 | 18367378 |
MESH:D004487 |
Edema |
|
Tetradecanoylphorbol Acetate |
3.48 | 9599246 11698051 8273558 8113982 16716910 7812673 15177302 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
4.32 | 18230668 |
MESH:D004701 |
Endocrine Gland Neoplasms |
|
trichostatin A |
5.49 | 19294695 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
3.01 | 16569247 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
2.04 | 20426865 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
3.46 | 16938888 9664655 |
MESH:D005234 |
Fatty Liver |
|
arsenite |
17.66 | 18296743 |
MESH:D005234 |
Fatty Liver |
|
Carbon Tetrachloride |
17.66 | 17595544 15959796 16239168 16045604 12631006 12795759 61145 19224547 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
17.66 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Dietary Fats |
17.66 | 18296743 17967931 19004024 19551842 |
MESH:D005354 |
Fibrosarcoma |
|
Methylcholanthrene |
4.79 | 10962813 14633661 |
MESH:D005355 |
Fibrosis |
|
arsenite |
26.15 | 18296743 |
MESH:D005355 |
Fibrosis |
|
Carbon Tetrachloride |
26.15 | 18705752 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
26.15 | 12168785 12639820 |
MESH:D005355 |
Fibrosis |
|
Dietary Fats |
26.15 | 18296743 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
26.15 | 17994277 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
4.53 | 16452187 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.07 | 8708960 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
7.09 | 17312396 |
MESH:D005909 |
Glioblastoma |
|
trichostatin A |
7.09 | 18801729 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
3.08 | 16096774 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
5.01 | 16084493 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
2.82 | 9664655 14991402 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.27 | 15720958 |
MESH:D006505 |
Hepatitis |
|
Carbon Tetrachloride |
3.45 | 19900420 19110552 |
MESH:D015658 |
HIV Infections |
|
Nickel |
3.74 | 17263646 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
3.03 | 12676792 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
3.09 | 16870215 |
MESH:D006932 |
Hyperbilirubinemia |
|
Carbon Tetrachloride |
4.38 | 16899240 |
MESH:D006937 |
Hypercholesterolemia |
|
Dietary Fats |
3.45 | 21332399 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
4.42 | 16778211 |
MESH:D006949 |
Hyperlipidemias |
|
Dietary Fats |
3.47 | 21332399 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
2.04 | 10903974 |
MESH:D006975 |
Hypertension, Portal |
|
Carbon Tetrachloride |
3.94 | 15338365 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
2.89 | 15346721 12646999 |
MESH:D007249 |
Inflammation |
|
Dietary Fats |
8.13 | 20412841 |
MESH:D007249 |
Inflammation |
|
Nickel |
8.13 | 16166738 |
MESH:D007249 |
Inflammation |
|
Tetradecanoylphorbol Acetate |
8.13 | 15177302 7562506 7812673 8273558 11698051 |
MESH:D007333 |
Insulin Resistance |
|
bisphenol A |
7.16 | 16393666 |
MESH:D007333 |
Insulin Resistance |
|
Dietary Fats |
7.16 | 11836018 18457598 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
3.62 | 17994277 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
3.76 | 15992940 17551590 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.29 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Cadmium |
9.68 | 16226777 16962696 16322080 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
9.68 | 10903974 18776723 8314463 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
9.68 | 20008137 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
2.61 | 12371664 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
2.70 | 17143497 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
3.56 | 16932348 19285840 16482212 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
4.07 | 17596541 19850784 16294345 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
trichostatin A |
4.07 | 18206229 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
3.05 | 19225113 16891316 17506722 17649720 17301526 16331271 16823087 17339181 19029980 19075265 17294898 9834237 12679006 17217047 16935935 19035177 16788101 17107899 17368321 16766008 17712046 17361223 16140955 15748426 19642359 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
3.20 | 9224671 |
MESH:D008103 |
Liver Cirrhosis |
|
arsenite |
10.62 | 18296743 |
MESH:D008103 |
Liver Cirrhosis |
|
Carbon Tetrachloride |
10.62 | 16221502 17157831 16239168 11903743 11408273 16943688 17334410 21278145 17174718 |
MESH:D008103 |
Liver Cirrhosis |
|
Dietary Fats |
10.62 | 18296743 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Carbon Tetrachloride |
2.44 | 15959796 17557913 16015684 18251166 18481824 18429990 14716833 18412020 18263696 15730626 17766677 12898905 15931870 17761835 12389079 12632514 15893842 15338365 11481614 15123356 17721639 12741479 15052691 18339082 14620537 18210741 14724832 18395914 10355542 12586293 12445418 15996030 12667390 17714472 15057751 18376398 16116963 15673190 18279442 12546737 18205269 17805973 16136751 16248980 18418968 15818738 12649538 15362042 12666154 16027843 15925388 17708605 13678700 16033810 17481882 14716496 17869086 15650968 18472332 18472094 17525996 12445421 17640975 14748882 17922224 12958196 15876570 18006644 16011737 17900296 18166357 18277467 18187930 17976157 17565644 18395095 12609069 17823541 18156304 14512876 16638106 20821823 16097048 18420326 17698563 18317297 15370692 18054572 17631135 17944888 16192424 12632512 18705752 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
2.44 | 16248980 18397230 |
MESH:D008107 |
Liver Diseases |
|
Carbon Tetrachloride |
4.53 | 16246199 16964402 15830285 15720792 17285989 |
MESH:D008107 |
Liver Diseases |
|
Tetrachloroethylene |
4.53 | 17267091 |
MESH:D017093 |
Liver Failure |
|
Carbon Tetrachloride |
4.01 | 15123358 |
MESH:D017114 |
Liver Failure, Acute |
|
Carbon Tetrachloride |
3.56 | 16899240 14706259 |
MESH:D008113 |
Liver Neoplasms |
|
Aflatoxin B1 |
7.16 | 18177683 15890375 2125692 9163691 |
MESH:D008113 |
Liver Neoplasms |
|
Carbon Tetrachloride |
7.16 | 19294768 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
7.16 | 15276417 16712894 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Aflatoxin B1 |
13.48 | 8603461 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Carbon Tetrachloride |
13.48 | 12014681 15583823 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Methylcholanthrene |
13.48 | 1399818 598648 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachloroethylene |
13.48 | 7955063 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
3.07 | 19095001 |
MESH:D008175 |
Lung Neoplasms |
|
Aflatoxin B1 |
6.43 | 14755239 |
MESH:D008175 |
Lung Neoplasms |
|
arsenite |
6.43 | 16809336 |
MESH:D008175 |
Lung Neoplasms |
|
Methylcholanthrene |
6.43 | 17909032 9230183 16337739 20970405 6695378 15390079 21163286 16271038 20512841 1399818 10545420 7750092 11893704 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
6.43 | 17306315 15276417 16712894 17077188 19931552 |
MESH:D008175 |
Lung Neoplasms |
|
Tetradecanoylphorbol Acetate |
6.43 | 11807781 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tetradecanoylphorbol Acetate |
3.26 | 8985016 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.73 | 17453147 |
MESH:D008545 |
Melanoma |
|
N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide |
7.18 | 16487513 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
7.18 | 19082730 16487513 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
7.18 | 16752155 |
MESH:D008545 |
Melanoma |
|
trichostatin A |
7.18 | 16505122 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
4.27 | 16940565 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.64 | 16801185 |
MESH:D052016 |
Mucositis |
|
irinotecan |
4.86 | 17159606 |
MESH:D009101 |
Multiple Myeloma |
|
trichostatin A |
3.76 | 18172295 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
2.99 | 17596541 |
MESH:D009362 |
Neoplasm Metastasis |
|
irinotecan |
3.11 | 18259882 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
8.08 | 11559025 |
MESH:D009369 |
Neoplasms |
|
Tetrachloroethylene |
8.08 | 11911487 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
8.08 | 16946489 16594593 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
3.52 | 20056578 |
MESH:D009389 |
Neovascularization, Pathologic |
|
arsenite |
4.26 | 15738583 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.29 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.15 | 19348381 18481113 |
MESH:D009421 |
Nervous System Malformations |
|
bisphenol A |
9.30 | 11399458 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
9.30 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
6.98 | 12854658 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
6.98 | 9142499 |
MESH:D009447 |
Neuroblastoma |
|
irinotecan |
3.40 | 8761367 |
MESH:D017599 |
Neuroectodermal Tumors |
|
irinotecan |
4.58 | 8761367 |
MESH:D009765 |
Obesity |
|
Dietary Fats |
2.25 | 17217161 18674790 11836018 20132043 20518802 21332399 18457598 16723640 19632207 |
MESH:D010049 |
Ovarian Diseases |
|
bisphenol A |
4.84 | 11985600 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
7.72 | 15276417 17306315 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
7.72 | 16936753 |
MESH:D010051 |
Ovarian Neoplasms |
|
trichostatin A |
7.72 | 19331143 |
MESH:D010146 |
Pain |
|
Tretinoin |
2.78 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide |
12.03 | 11504793 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tetradecanoylphorbol Acetate |
12.03 | 15976015 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
12.03 | 15976015 |
MESH:D010190 |
Pancreatic Neoplasms |
|
trichostatin A |
12.03 | 19294695 |
MESH:D010212 |
Papilloma |
|
Tetradecanoylphorbol Acetate |
4.14 | 18922899 12065085 8330346 18404319 |
MESH:D016491 |
Peripheral Vascular Diseases |
|
Cadmium |
5.23 | 15687053 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.09 | 12371664 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
bisphenol A |
3.80 | 10548101 |
MESH:D055728 |
Primary Myelofibrosis |
|
trichostatin A |
5.10 | 17616702 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
bisphenol A |
4.07 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
bicalutamide |
1.92 | 18487222 17914592 19240160 15638997 19011039 |
MESH:D011471 |
Prostatic Neoplasms |
|
bisphenol A |
1.92 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Cadmium |
1.92 | 17075824 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
1.92 | 16039940 |
MESH:D011471 |
Prostatic Neoplasms |
|
trichostatin A |
1.92 | 19789329 18798265 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
3.46 | 16636307 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.18 | 16882103 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
4.64 | 16723453 |
MESH:D011629 |
Puberty, Precocious |
|
bisphenol A |
4.63 | 10548101 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
3.96 | 16283617 16116481 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
9.19 | 19524636 18572023 |
MESH:D012878 |
Skin Neoplasms |
|
Tetradecanoylphorbol Acetate |
9.19 | 8330346 12065085 8985016 11807781 18404319 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
9.19 | 16467112 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
3.68 | 12854658 |
MESH:D013274 |
Stomach Neoplasms |
|
irinotecan |
2.60 | 15723263 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
2.60 | 17261132 |
MESH:D019966 |
Substance-Related Disorders |
|
bisphenol A |
3.83 | 16045194 16684133 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
2.91 | 16026305 17045167 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
3.65 | 16051514 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
3.13 | 16040207 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
2.45 | 17306315 16712894 16452187 11723127 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
8.96 | 11813266 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
8.96 | 16129372 |
MESH:D014591 |
Uterine Diseases |
|
bisphenol A |
4.86 | 14652134 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
4.46 | 16752155 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
3.83 | 1336536 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
4.27 | 17056641 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
3.91 | 16761959 |
MESH:D015430 |
Weight Gain |
|
Dietary Fats |
3.61 | 16723640 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
3.84 | 16287080 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.29 | 17120751 |